Washington, DC 20006-5349
HELPLINE
For MesoTV, we brought back a valuable conversation about complementary vs alternative therapies from a previous conference on malignant mesothelioma in New York City. In…
Elliot Wakeam, MD, discussed mesothelioma treatment at the University of Michigan. Dr. Wakeam is a thoracic and lung transplant surgeon and assistant professor who uses…
Adnan Jaigirdar, MD, FACS, provides an overview of the U.S. Food and Drug Administration (FDA) expanded access program (compassionate use) for investigative therapies for mesothelioma patients. Dr. Jaigirdar is…
Five mesothelioma patients — Heather Von St. James, Rich Mosca, Liam Bradley, John Panza and Sara Babin — gathered for a community panel discussion on…
Liz Darlison, head of services at Mesothelioma UK, spoke with Mary Hesdorffer, NP, about mesothelioma treatment in the United Kingdom during COVID-19 and in general. Liz is a…
Join us next Tuesday, June 9 at 2:00 PM ET for a Meet the Mesothelioma Experts (MTME) interview with Dr. Zachary Horne on Facebook Live.…
Anna Nowak, MD, PhD, speaks about immunotherapy and combination of immunotherapy and chemotherapy for mesothelioma patients. She also discusses COVID-19’s effects on mesothelioma in treatment in Australia.…
Buerkley Rose, MSN, RN, discusses how the University of Chicago’s mesothelioma program has adapted during the COVID-19 pandemic: Clinical Trials: Paused. Telemedicine, including psycho-oncology services: Available. Surgery:…
Members of the mesothelioma treatment team at the University of Maryland Medical Center — Joseph Friedberg, MD; Melissa Culligan, RN, MS; and Erica Glass, NP…
Mary Hesdorffer, NP, executive director of the Mesothelioma Applied Research Foundation, interviewed mesothelioma expert Dr. Daniel Sterman, NYU, to discuss the current situation in New…
